Newly Published Peer-Reviewed Study Shows Efficacy of Equashield CSTD in Preventing Hazardous Drug Contamination When Compounding Cytotoxic Medications in RealWorld Setting
25 août 2021
PORT WASHINGTON, New York, Aug. 24, 2021 /PRNewswire/ -- Equashield (equashield.com), a leading provider of…
The Time is Ripe for an Alternative to Automated Hazardous Drug Compounding
7 mai 2020
One area in which automation is not currently being utilized to its fullest potential is…